advert
advert
Angel News

Back to Homepage

22nd July 2021 - 0 comments

TravelPerk cofounder launches mental health startup Oliva

TravelPerk cofounder launches mental health startup Oliva backed by Moonfire Ventures.

21st July 2021 - 0 comments

New UK virus killing PPE firm Viracoat raises £2m from Australia

Viracoat, a subsidiary of Viracorp set up to develop and produce PPE that begins killing COVID-19 and other viruses on contact, has raised £2million ($4million Australian dollars) to fund final stages of accreditation and further UK based research. The funding comes from J.J. Richards & Sons Pty Ltd, an Australian, family owned and operated business that provides waste management service solutions throughout Australia and New Zealand and already has a successful scientific and medical distribution subsidiary.

21st July 2021 - 0 comments

Tencent invests €29.5m in Sweden's Doktor.se

Sweden’s largest providers of digital healthcare, Doktor.se, has secured €29.5 million from Tencent Holdings.

19th July 2021 - 0 comments

‘Revolutionary woundcare’ biotech firm raises £1.8m from MEIF

A biotech company with a product that helps to heal eye injuries and could revolutionise treatment of other wounds has raised a further £1.8m.

Nottingham-based NuVision Biotherapies  has secured funding from the MEIF Proof of Concept & Early Stage Fund, which is managed by Mercia and part of the Midlands Engine Investment Fund, Mercia’s EIS funds, Newable Ventures and private investors.

16th July 2021 - 0 comments

Praetura Ventures leads £2.9m investment in Reacta Biotech

A business that is on course to transform the food allergy diagnostics market has secured £2.9m investment in a funding round led by Praetura Ventures with follow-on equity investment from the Development Bank of Wales.  Reacta Biotech (Reacta), which is based in Deeside, North Wales, produces clinical diagnostics kits for food allergy testing. The business improves the efficiency, accuracy and safety of food allergy testing by producing pharmaceutical grade Oral Food Challenges (OFCs), the gold standard test for diagnosing food allergies.

16th July 2021 - 0 comments

Livingbridge invests in leading provider of NHS wheelchair services AJM Healthcare

Livingbridge has announced its investment in AJM Healthcare, the leading provider of NHS wheelchair services in England.  AJM provides services for over 100,000 wheelchair users across 13 locations.  It delivers a high quality, clinically led service focused on meeting the diverse needs of users.  AJM draws on the deep experience of its more than 270 staff to ensure leading outcomes and best-in-class service for both commissioners and service users.

14th July 2021 - 0 comments

IW Capital backs e-pharmacy platform SimplyMeds

IW Capital has made an investment in e-pharmacy company SimplyMeds, marking the first external investment in the highly scalable online platform.

SimplyMeds is an end-to-end digital pharmacy platform that provides a convenient method of ordering same day prescriptions and lifestyle products while empowering patients to have medical autonomy. While most online pharmacies are designed to service only one sector, SimplyMeds caters to both the private and NHS prescriptions market in what is believed to be a market first, having developed the distribution channels and a highly sophisticated platform to effectively serve both sectors. 

13th July 2021 - 0 comments

Remedi Pharmacy Solutions secures £250,000 MEIF loan

Pharmaceutical business Remedi Pharmacy Solutions has secured a £250,000 loan to support the development of its latest software platform and enable it to create seven new jobs.

9th July 2021 - 0 comments

Kuano.ai raises £1m seed to de-risk and accelerate drug discovery

Kuano.aia software platform for rapid, cost effective quantum modelling of enzymes, has raised £1 million in seed funding from ACF Investors, o2h Ventures and a syndicate of Cambridge-based angel investors. The funding will accelerate the company’s growth as it moves further towards commercialisation.

9th July 2021 - 0 comments

Foresight invests £1.5m into Biotherapy Services

Foresight Group, the award-winning listed private equity and infrastructure investment manager, has announced a £1.5m follow-on investment into portfolio company Biotherapy Services Ltd, a leading pharmaceutical biotech company.  The funds will be used to support the clinical development of RAPIDTM Biodynamic Haematogel, currently in phase 2b/3 clinical trials in the treatment of DFUs.

7th July 2021 - 0 comments

Brain cancer startup QV Bioelectronics raises £750k

QV Bioelectronics – a medical device start-up pioneering a first of its kind electric field therapy implant for the treatment of the most common and aggressive type of brain tumours, has closed a £735,000 seed funding round to advance the development of its innovative GRACE implant.

6th July 2021 - 0 comments

MediSieve raises £1.8m from 24Haymarket to pursue its trials

MediSieve Ltd, a biotech company which has developed an innovative blood filtration device, has completed a £1.8m investment, led by 24Haymarket.

PREVIOUSItems 228 of 573NEXT

Back to Homepage